Bill Information > SB 6421
Search for another bill or initiative:
SB 6421 - 2015-16
Authorizing the use of epinephrine autoinjector devices through collaborative agreements.
Sponsors: Ranker, Becker, McAuliffe, Mullet
Bill History

2016 REGULAR SESSION

Jan 20
First reading, referred to Health Care. (View Original Bill)
Jan 26
Public hearing in the Senate Committee on Health Care at 10:00 AM. (Committee Materials)
Feb 4
Executive action taken in the Senate Committee on Health Care at 10:00 AM. (Committee Materials)
Feb 5
HLTH - Majority; 1st substitute bill be substituted, do pass. (View 1st Substitute) (Majority Report)
Passed to Rules Committee for second reading.
Feb 8
Placed on second reading by Rules Committee.
Feb 15
1st substitute bill substituted (HLTH 16). (View 1st Substitute)
Rules suspended. Placed on Third Reading.
Third reading, passed; yeas, 48; nays, 0; absent, 0; excused, 1. (View Roll Calls)

IN THE HOUSE

Feb 17
First reading, referred to Health Care & Wellness (Not Officially read and referred until adoption of Introduction report).
Feb 23
Public hearing in the House Committee on Health Care & Wellness at 8:00 AM. (Committee Materials)
Feb 24
Executive action taken in the House Committee on Health Care & Wellness at 1:30 PM. (Committee Materials)
HCW - Majority; do pass. (Majority Report)
Feb 25
Referred to Rules 2 Review.
Feb 29
Placed on second reading.
Mar 2
Rules suspended. Placed on Third Reading.
Third reading, passed; yeas, 96; nays, 1; absent, 0; excused, 1. (View Roll Calls)

IN THE SENATE

Mar 3
President signed.

IN THE HOUSE

Mar 4
Speaker signed.

OTHER THAN LEGISLATIVE ACTION

Mar 4
Delivered to Governor. (View Bill as Passed Legislature)
Mar 10
Governor signed.
Chapter 10, 2016 Laws. (View Session Law)
Effective date 6/9/2016.
Available Documents
For a complete list of documents, go to Online Reports Text of a Legislative Document.
Fiscal Note
Amendments
Available Videos